A Prospective, Single-center, Single-Arm, Interventional Study to Assess the Efficacy(in alleviating the symptoms of ocular dryness) and Safety of Systane Ultra in subjectswith dry eye due to Computer Vision Syndrome (CVS)

Dr Agarwals eye hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•. Male/female of >=18 and <=45 years of age
•2. Participant who can and willing to provide written Informed Consent
•3. Participant more prone to computer use â?? daily computer / visual display unit
•(VDU) use > 3 hours per day /15 hours per week
•4. Participant with minimum 3 months exposure to any VDU
•5. Participant with CVS-Q score >= 6
•6. Participant with OSDI Score 23-32 (both inclusive) with dry eye symptoms
•7. Participant with TBUT < 10 at the time of screening
•8. Participant is nonsmoker
•9. Participant/ patientâ??s legally acceptable representative having an ability to
•understand the disease and its treatment and follow protocol requirements

•1. Participants Ë? 18 or Ë? 45 years of age
•2. Participants using contact lenses within last 6 months
•3. Participants having a history of systemic disease, other ocular pathologies or on
•prior treatment for the same
•4. Participants with a history of intra or extraocular surgery or planning to undergo
•ocular or eyelid surgery
•5. Participants taking previous treatment with steroids, isotretinoin or
•immunosuppressive drugs
•6. Patient with any other clinically significant illness
•7. Patient who has participated in another trial with an investigational drug within 6
•months prior to this trial.
•8. Patient with any other condition, which as per the investigator would jeopardize the
•outcome of the trial
•9. Patients who, in the judgment of the investigator, will be unlikely to comply with
•the requirements of this protocol

发起方

Dr Agarwals eye hospital